An observational study in Enuresis, Nocturnal, Ganglion and Circadian Rhythm Disorders, sponsored by Izmir Bakircay University. Status unknown at 1 site in Turkey. Open to participants aged 5 Years to 18 Years. Per ClinicalTrials.gov, last updated 2021-11-19.
Sponsored by Izmir Bakircay University · Observational
The precise role of the intrinsic circadian regulatory mechanism behind the pathogenesis of enuresis is not fully understood, but in theory, circadian rhythm irregularity may be the primary pathogenic mechanism not only for urinary outflow mechanisms but also for nocturnal bladder function. The proximity between SCN centers that control AVP release, sleep/arousal, voiding, and baroreregulation may provide the basis for circadian rhythm disturbance in one or more of these biological functions. Ganglion cells containing melanopsin pigment in the retina transmit the information they receive from the outside world about the light-dark state to the SCN via the retinohypothalamic pathway. Peripapillary retinal nerve fiber layer (RNFL) thickness, optic nerve head and macula are examined most frequently for the diagnosis of glaucoma and the detection of progression with optical coherence tomography (OCT). If differences in ganglion cell thickness can be detected using OCT in these children, a new avenue in Enuresis Nocturna may be opened.
136 studies on the registry are indexed under Ganglion Cysts; 28 are open to participants now.
This study's planned enrollment of 50 is above the median of 44 across 28 observational studies indexed under Ganglion Cysts.
Browse Ganglion Cysts studies →Izmir Bakircay University is the lead sponsor of 73 studies on the registry; 17 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Pediatric patients aged 5-18 years, with enuresis, without any eye disease
Exclusion Criteria:
Difference in ganglion cell thickness in enuretic children
Normal values in RNFL measurements on OCT 75 (lowest)-107.2 (highest)
Time frame: Baseline
This study is status unknown, as verified in Nov 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Izmir Bakircay University